PK of Serelaxin in Severe Renal Impairment and ESRD
Clinical trial NCT01875523 · COMPLETED
Trial details
- NCT number
- NCT01875523
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2013-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.